BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2780462)

  • 1. Long-term symptomatic relief of postprandial hypoglycaemia following gastric surgery with a somatostatin analogue.
    D'Cruz DP; Reynard J; Tatman AJ; Kopelman PG
    Postgrad Med J; 1989 Feb; 65(760):116-7. PubMed ID: 2780462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The place of octreotide in the medical management of the dumping syndrome.
    Scarpignato C
    Digestion; 1996; 57 Suppl 1():114-8. PubMed ID: 8813487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long acting somatostatin analogue in dumping syndrome.
    Tulassay Z; Tulassay T; Gupta R; Cierny G
    Br J Surg; 1989 Dec; 76(12):1294-5. PubMed ID: 2691013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postgastrectomy dumping treated with octreotide (Sandostatin)].
    Møller TD; Carlsen CU
    Ugeskr Laeger; 1993 Jun; 155(23):1805-6. PubMed ID: 8317033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide improves early dumping syndrome potentially through incretins: a case report.
    Sato D; Morino K; Ohashi N; Ueda E; Ikeda K; Yamamoto H; Ugi S; Yamamoto H; Araki S; Maegawa H
    Endocr J; 2013; 60(7):847-53. PubMed ID: 23708181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.
    Lamers CB; Bijlstra AM; Harris AG
    Dig Dis Sci; 1993 Feb; 38(2):359-64. PubMed ID: 8425449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting analogue of somatostatin--SMS 201-995--is highly effective in the prevention of clinical symptoms related to the dumping syndrome.
    Tulassay Z; Tulassay T; Gupta R; Cierny G
    Ann Surg; 1989 Aug; 210(2):250-2. PubMed ID: 2757427
    [No Abstract]   [Full Text] [Related]  

  • 8. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.
    Richards WO; Geer R; O'Dorisio TM; Robarts T; Parish KL; Rice D; Woltering G; Abumrad NN
    J Surg Res; 1990 Dec; 49(6):483-7. PubMed ID: 2263084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy.
    Primrose JN; Johnston D
    Br J Surg; 1989 Feb; 76(2):140-4. PubMed ID: 2702445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
    Arts J; Caenepeel P; Bisschops R; Dewulf D; Holvoet L; Piessevaux H; Bourgeois S; Sifrim D; Janssens J; Tack J
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):432-7. PubMed ID: 19264574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe postgastrectomy dumping with a long-acting somatostatin analog: is effective management finally available?
    Miller TA
    Gastroenterology; 1991 Oct; 101(4):1129-30. PubMed ID: 1889706
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.
    Hopman WP; Wolberink RG; Lamers CB; Van Tongeren JH
    Ann Surg; 1988 Feb; 207(2):155-9. PubMed ID: 2893592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.
    Geer RJ; Richards WO; O'Dorisio TM; Woltering EO; Williams S; Rice D; Abumrad NN
    Ann Surg; 1990 Dec; 212(6):678-87. PubMed ID: 2256759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide in the treatment of the dumping syndrome.
    Primrose JN
    Digestion; 1990; 45 Suppl 1():49-58; discussion 58-9. PubMed ID: 2335268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of octreotide-therapy in severe dumping syndrome.
    Vecht J; Lamers CB; Masclee AA
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):619-24. PubMed ID: 10594523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery.
    Gray JL; Debas HT; Mulvihill SJ
    Arch Surg; 1991 Oct; 126(10):1231-5; discussion 1235-6. PubMed ID: 1929823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin and the dumping syndrome.
    Long RG; Adrian TE; Bloom SR
    Br Med J (Clin Res Ed); 1985 Mar; 290(6472):886-8. PubMed ID: 2858244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of nonendocrine gastrointestinal disorders with octreotide acetate.
    Woltering EA; O'Dorisio TM; Williams ST; Lebrado L; Fletcher WS
    Metabolism; 1990 Sep; 39(9 Suppl 2):176-9. PubMed ID: 1976212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
    Penning C; Vecht J; Masclee AA
    Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Could delayed action flanreotide be used as substitute for octreotide in the treatment of dumping syndrome?].
    Bouché O; Salmon-Ettersperger L; Frémond L; Thiéfin G; Zeitoun P
    Gastroenterol Clin Biol; 1997; 21(1):84-5. PubMed ID: 9091398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.